Research ArticleCancer

Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers

+ See all authors and affiliations

Science Translational Medicine  12 Jul 2017:
Vol. 9, Issue 398, eaah5583
DOI: 10.1126/scitranslmed.aah5583

Article Information

vol. 9 no. 398

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication July 13, 2016
  • Resubmitted December 16, 2016
  • Accepted for publication April 27, 2017

Author Information

  1. Jungsun Kim1,
  2. William R. Bamlet2,
  3. Ann L. Oberg2,
  4. Kari G. Chaffee2,
  5. Greg Donahue1,
  6. Xing-Jun Cao3,
  7. Suresh Chari4,
  8. Benjamin A. Garcia3,
  9. Gloria M. Petersen5 and
  10. Kenneth S. Zaret1,*
  1. 1Institute for Regenerative Medicine, Department of Cell and Developmental Biology, Abramson Cancer Center (Tumor Biology Program), Perelman School of Medicine, University of Pennsylvania, 9-131 Smilow Center for Translational Research, 3400 Civic Center Boulevard, Philadelphia, PA 19104–5157, USA.
  2. 2Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
  3. 3Epigenetics Program, Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  4. 4Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
  5. 5Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
  1. *Corresponding author. Email: zaret{at}upenn.edu

AltMetrics

Article usage

AbstractFullPDF
Jul 20179322540927